We would like to invite you to the inaugural lecture of Professor Chris McDermott which will be held on Friday 20th April 2018.
Title: Helping Patients Survive the Experts
Date and time: Friday 20th April 2018 – 4.30pm
Venue: Sheffield Institute for Translational Neuroscience (SITraN)
This will be followed by a wine reception
Prof McDermott studied for his medical degree at the University in Leeds graduating in 1994. He then continued his general medical and specialist neurology training in Leeds before taking up a clinical research training fellowship at the University of Newcastle upon Tyne. He moved to the University of Sheffield with Professor Dame Pamela Shaw in 2000 to undertake his Wellcome Trust Doctoral Training Fellowship and to complete his Specialist Training in Neurology to become a Consultant Neurologist in 2006. Prof McDermott is now the Professor of Translational Neurology and Head of Department in the Department of Neuroscience at the University of Sheffield. He is also Co-Director of the MND care and research centre and a Consultant Neurologist at the Sheffield Teaching Hospitals Foundation NHS Trust, regularly undertaking specialist MND and neuromuscular clinics. He holds a number of external advisory positions with NICE, NIHR, the Association of British Neurologists and the Motor Neurone Disease Association. He chairs the national MND UK clinical studies group. His work is funded by NIHR, MND Association, JPND, EU2020 and Marie Curie.
The main drive of Prof McDermott’s research programme is developing the evidence base for delivering supportive and symptomatic care for patients living with motor neuron disease. He is also interested in studying mechanisms of neurodegeneration, in order to develop and then evaluate treatments for patients with motor neuron disease and hereditary spastic paraplegia. “Helping patients survive the experts” will highlight Prof McDermott’s work on the issues facing healthcare professionals and people living with MND when deciding what treatments are best and demonstrate the advantageous of allowing people living with MND direct and collaborate in research. We look forward to welcoming you all.